Twin City Private Wealth’s Pfizer PFE Stock Holding History

Twin City Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Buy	43,893 +784	+2%	+$20.5K	0.74%	55
2026 Q1	$1.21M	Sell	43,109 -453	-1%	-$12.1K	0.92%	43
2025 Q4	$1.08M	Sell	43,562 -2,199	-5%	-$55.5K	0.82%	44
2025 Q3	$1.17M	Buy	45,761 +1,252	+3%	+$30.9K	0.91%	42
2025 Q2	$1.08M	Buy	44,509 +1,769	+4%	+$41.3K	0.88%	48
2025 Q1	$1.08M	Buy	42,740 +2,608	+6%	+$68.2K	0.95%	40
2024 Q4	$1.06M	Sell	40,132 -5,160	-11%	-$140K	0.94%	43
2024 Q3	$1.31M	Sell	45,292 -705	-2%	-$20.6K	1.14%	39
2024 Q2	$1.29M	Sell	45,997 -1,407	-3%	-$38.7K	1.22%	37
2024 Q1	$1.32M	Buy	+47,404	New	+$1.32M	1.3%	35

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Twin City Private Wealth's PFE Position: Q2 2026 in Review

Twin City Private Wealth increased its Pfizer (PFE) stake by 1.8% in Q2 2026, buying an estimated $20.5K and bringing the position to 43,893 shares worth $1.06M. The position accounts for 0.74% of the portfolio, ranked #55.

Twin City Private Wealth first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.32M in Q1 2024. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Twin City Private Wealth held 43,893 shares of Pfizer worth $1.06M as of Q2 2026.
Twin City Private Wealth bought 784 Pfizer shares in Q2 2026, an estimated $20.5K.
Pfizer made up 0.74% of Twin City Private Wealth's portfolio in Q2 2026, its #55 holding.
Twin City Private Wealth first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
Twin City Private Wealth's Pfizer position peaked at $1.32M in Q1 2024.
2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Twin City Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.